EXHIBIT 99.1
ATHEROGENICS, INC.
(Debtor-in-Possession)
BALANCE SHEET
May 31, 2009
(Unaudited)
| | | | |
Assets | | | | |
Current assets: | | | | |
Cash and cash equivalents | | $ | 46,570,341 | |
Prepaid expenses | | | 185,999 | |
Interest receivable and other current assets | | | 11,602 | |
| | | |
Total current assets | | | 46,767,942 | |
| | | | |
Equipment and leasehold improvements, net of accumulated depreciation and amortization | | | — | |
| | | |
Total assets | | $ | 46,767,942 | |
| | | |
| | | | |
Liabilities and Shareholders’ Deficit | | | | |
Current liabilities: | | | | |
Accounts payable | | $ | 211,717 | |
Accrued professional fees | | | 278,676 | |
Accrued and other liabilities | | | 12,163 | |
| | | |
Total current liabilities not subject to compromise | | | 502,556 | |
| | | | |
Prepetition liabilities | | | 306,890,836 | |
| | | | |
Shareholders’ deficit | | | | |
Common stock | | | 219,855,598 | |
Warrants | | | 598,173 | |
Accumulated deficit | | | (481,079,221 | ) |
| | | |
Total shareholders’ deficit | | | (260,625,450 | ) |
| | | |
Total liabilities and shareholders’ deficit | | $ | 46,767,942 | |
| | | |
ATHEROGENICS, INC.
(Debtor-in-Possession)
STATEMENT OF OPERATIONS
For the month ended May 31, 2009
(Unaudited)
| | | | |
Revenues | | $ | — | |
| | | | |
Operating expenses: | | | | |
Research and development | | | — | |
General and administrative | | | 86,693 | |
| | | |
Total operating expenses | | | 86,693 | |
| | | |
| | | | |
Net loss before reorganization items | | | (86,693 | ) |
| | | | |
Reorganization items, net | | | (277,624 | ) |
| | | |
| | | | |
Net loss | | $ | (364,317 | ) |
| | | |
| | | | |
Net loss per share — basic and diluted | | $ | (0.01 | ) |
| | | |
| | | | |
Weighted average shares outstanding — basic and diluted | | | 39,518,492 | |
| | | |